It functions by blocking FAK autophosphorylation—particularly at tyrosine residues Y397 and Y925—thereby disrupting integrin-mediated signalling cascades, including the RAS/MEK/ERK and PI3K/Akt pathways, which are involved in tumour cell proliferation, survival, migration, and angiogenesis [12]. Here, PTK2 is linked to neoplasm.